Download PDF
Thromb Haemost 1996; 75(06): 976-977
DOI: 10.1055/s-0038-1650407
Original Article
Schattauer GmbH Stuttgart

Specificity of an Assay Based on a Factor V-depleted Plasma in Patients Carrying the Arg 506 GIn Mutation

M Alhenc-Gelas
1   The Laboratoire d’Hémostase, Hôpital Broussais, Paris
,
M F Aillaud
2   Laboratoire d’Hématologie, Hôpital La Timone, Marseille
,
M N Bonvarlet
3   R & D Hémostase, Société bio Mérieux, Marcy-1’Etoile, France
,
G Dupuy
3   R & D Hémostase, Société bio Mérieux, Marcy-1’Etoile, France
,
I Juhan-Vague
2   Laboratoire d’Hématologie, Hôpital La Timone, Marseille
,
M Aiach
1   The Laboratoire d’Hémostase, Hôpital Broussais, Paris
› Author Affiliations
Further Information

Publication History

Received 08 December 1995

Accepted after resubmission 12 March 1996

Publication Date:
27 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 2 Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 3 Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
    CrossrefPubMedGoogle Scholar
  • 4 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993
    PubMedGoogle Scholar
  • 5 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 6 Zoller B, Svensson PJ, He X, Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524
    CrossrefPubMedGoogle Scholar
  • 7 de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-886
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Sun X, Evatt B, Griffin JH. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 1994; 83: 3120-3126
    PubMedGoogle Scholar
  • 9 Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162-1163
    PubMedGoogle Scholar
  • 10 Trossaert M, Conard J, Horellou MH, Samama MM, Ireland H, Bayston TA, Lane D. Modified resistance assay for patients on oral anticoagulants. Lancet 1994; 344: 1709-1710
    PubMedGoogle Scholar
  • 11 Tosetto A, Rodeghiero F. Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thromb Haemost 1995; 73: 732-733
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Cadroy Y, Sié P, Alhenc-Gelas M, Aiach M. Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants. Thromb Haemost 1995; 73: 734
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Dahlback B. Modified APC-resistance test offers increased sensitivity and specificity for the FV:Q506 allele. Thromb Haemost 1995; 74: 1380-1381
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Le DT, Griffin JH, Greengard JS, Mujumdar V, Rapaport S. Use of a generally applicable tissue factor-dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. Blood 1995; 85: 1704-1711
    PubMedGoogle Scholar
  • 15 Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg 506 Gin mutation. Blood Coag Fibrinol 1995; 6: 245-249
    CrossrefPubMedGoogle Scholar